Development and validation of a nomogram for predicting survival of breast cancer patients with ipsilateral supraclavicular lymph node metastasis

Impact of Ipsilateral Supraclavicular Lymph Node Dissection (ISLND) for Breast Cancer Patients and a Nomogram for Predicting Ipsilateral Supraclavicular Pathological Complete Response (ispCR)

(2021) Minhao Lv et al.   ANNALS OF SURGICAL ONCOLOGY

Neoadjuvant docetaxel with or without carboplatin plus dual HER2 blockade for HER2-positive breast cancer: a retrospective multi-center Chinese study

(2020) Minhao Lv et al.   Gland Surgery

Surgery of the Primary Tumor Offers Survival Benefits of Breast Cancer with Synchronous Ipsilateral Supraclavicular Lymph Node Metastasis

(2019) Qi-tong Chen et al.   WORLD JOURNAL OF SURGERY

Development and validation of a nomogram predicting the overall survival of stage IV breast cancer patients

(2017) Shunrong Li et al.   Cancer Medicine

Lymph Node Ratio Analysis After Neoadjuvant Chemotherapy is Prognostic in Hormone Receptor-Positive and Triple-Negative Breast Cancer

(2016) Jacqueline Tsai et al.   ANNALS OF SURGICAL ONCOLOGY

Nomograms to estimate long-term overall survival and breast cancer-specific survival of patients with luminal breast cancer

(2016) Wei Sun et al.   Oncotarget

The Prognostic Value of Lymph Node Ratio in Node-Positive Breast Cancer: A Dutch Nationwide Population-Based Study

(2013) Pim J. M. Dings et al.   ANNALS OF SURGICAL ONCOLOGY

Outcomes of Patients With Breast Cancer Who Present With Ipsilateral Supraclavicular or Internal Mammary Lymph Node Metastases

(2013) Silvia Dellapasqua et al.   Clinical Breast Cancer

Predicting and Communicating the Risk of Recurrence and Death in Women With Early-Stage Breast Cancer: A Systematic Review of Risk Prediction Models

(2013) Ellen G. Engelhardt et al.   JOURNAL OF CLINICAL ONCOLOGY

Lymph node ratio and pN staging in patients with node-positive breast cancer: a report from the Korean breast cancer society

(2011) Sei Hyun Ahn et al.   BREAST CANCER RESEARCH AND TREATMENT

Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational Trial

(2011) John M.S. Bartlett et al.   JOURNAL OF CLINICAL ONCOLOGY

Improved Staging in Node-Positive Breast Cancer Patients Using Lymph Node Ratio: Results in 1,788 Patients with Long-term Follow-Up

(2010) Melissa E. Danko et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Lymph Node Ratio as an Alternative to pN Staging in Node-Positive Breast Cancer

(2009) Vincent Vinh-Hung et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

(2009) Kathy S Albain et al.   LANCET ONCOLOGY

The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti-HER-2 Therapy and Personalized Medicine

(2009) J. S. Ross et al.   ONCOLOGIST

Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy

(2008) Bhumsuk Keam et al.   BREAST CANCER RESEARCH AND TREATMENT